AngloAmerican
temporarily constrained until higher grade ore from new phases | AngloAmerican
Company
Deck Type
Deck date
February 2024
Slide
55 of 88
Related slides by other companies
Equillium
Investor Presentation
February 2024
phase study of in adults with moderate to severe potential target product profile alternative to with at least comparable efficacy patient administered weekly weekly subcutaneous injection similar to | Equillium
Nuvalent
Investor Presentation
February 2024
pipeline advancing a portfolio of potentially best in class products with complementary initial indications in lead indication product candidate discovery enabling phase phase anticipated milestones rights open enrolling phase portion phase trial data update medical meeting alk open enrolling phase portion phase trial phase initiation data update medical meeting her phase initiation undisclosed targets additional discovery research programs ongoing key milestone achieved planned milestone | Nuvalent
Equillium
Investor Presentation
December 2023
phase study of in adults with moderate to severe target product profile alternative to with at least comparable efficacy patient administered weekly weekly subcutaneous injection similar to | Equillium
Compass Therapeutics
Investor Presentation
May 2023
treatment emergent grade adverse events of patients | Compass Therapeutics
Other recent decks by AngloAmerican
See all presentations (26 decks)
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
October 2023
Investor Presentation
October 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io